Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach

Ten-year follow-up data analyzed with marginal structural models and propensity score methods

Michael McCulloch, Michael Broffman, Mark Van Der Laan, Alan Hubbard, Lawrence Kushi, Donald I. Abrams, Jin Gao, John M. Colford

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Although localized colon cancer is often successfully treated with surgery, advanced disease requires aggressive systemic therapy that has lower effectiveness. Approximately 30% to 75% of patients with colon cancer use complementary and alternative medicine (CAM), but there is limited formal evidence of survival efficacy. In a consecutive case series with 10-year follow-up of all colon cancer patients (n = 193) presenting at a San Francisco Bay-Area center for Chinese medicine (Pine Street Clinic, San Anselmo, CA), the authors compared survival in patients choosing short-term treatment lasting the duration of chemotherapy/radiotherapy with those continuing long-term. To put these data into the context of treatment responses seen in conventional medical practice, they also compared survival with Pan-Asian medicine + vitamins (PAM+V) with that of concurrent external controls from Kaiser Permanente Northern California and California Cancer Registries. Kaplan-Meier, traditional Cox regression, and more modern methods were used for causal inference-namely, propensity score and marginal structural models (MSMs), which have not been used before in studies of cancer survival and Chinese herbal medicine. PAM+V combined with conventional therapy, compared with conventional therapy alone, reduced the risk of death in stage I by 95%, stage II by 64%, stage III by 29%, and stage IV by 75%. There was no significant difference between short-term and long-term PAM+V. Combining PAM+V with conventional therapy improved survival, compared with conventional therapy alone, suggesting that prospective trials combining PAM+V with conventional therapy are justified.

Original languageEnglish (US)
Pages (from-to)240-259
Number of pages20
JournalIntegrative Cancer Therapies
Volume10
Issue number3
DOIs
StatePublished - Sep 2011
Externally publishedYes

Fingerprint

Propensity Score
Herbal Medicine
Structural Models
Systems Analysis
Vitamins
Colonic Neoplasms
Survival
Medicine
Therapeutics
Complementary Therapies
San Francisco
Registries
Neoplasms
Radiotherapy
Drug Therapy

Keywords

  • chemotherapy
  • Chinese herbal medicine
  • colon cancer
  • marginal structural models
  • propensity score
  • radiotherapy
  • survival
  • vitamins

ASJC Scopus subject areas

  • Complementary and alternative medicine
  • Oncology

Cite this

Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach : Ten-year follow-up data analyzed with marginal structural models and propensity score methods. / McCulloch, Michael; Broffman, Michael; Van Der Laan, Mark; Hubbard, Alan; Kushi, Lawrence; Abrams, Donald I.; Gao, Jin; Colford, John M.

In: Integrative Cancer Therapies, Vol. 10, No. 3, 09.2011, p. 240-259.

Research output: Contribution to journalArticle

McCulloch, Michael ; Broffman, Michael ; Van Der Laan, Mark ; Hubbard, Alan ; Kushi, Lawrence ; Abrams, Donald I. ; Gao, Jin ; Colford, John M. / Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach : Ten-year follow-up data analyzed with marginal structural models and propensity score methods. In: Integrative Cancer Therapies. 2011 ; Vol. 10, No. 3. pp. 240-259.
@article{132433180b43486b89536b4cc5f7061c,
title = "Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: Ten-year follow-up data analyzed with marginal structural models and propensity score methods",
abstract = "Although localized colon cancer is often successfully treated with surgery, advanced disease requires aggressive systemic therapy that has lower effectiveness. Approximately 30{\%} to 75{\%} of patients with colon cancer use complementary and alternative medicine (CAM), but there is limited formal evidence of survival efficacy. In a consecutive case series with 10-year follow-up of all colon cancer patients (n = 193) presenting at a San Francisco Bay-Area center for Chinese medicine (Pine Street Clinic, San Anselmo, CA), the authors compared survival in patients choosing short-term treatment lasting the duration of chemotherapy/radiotherapy with those continuing long-term. To put these data into the context of treatment responses seen in conventional medical practice, they also compared survival with Pan-Asian medicine + vitamins (PAM+V) with that of concurrent external controls from Kaiser Permanente Northern California and California Cancer Registries. Kaplan-Meier, traditional Cox regression, and more modern methods were used for causal inference-namely, propensity score and marginal structural models (MSMs), which have not been used before in studies of cancer survival and Chinese herbal medicine. PAM+V combined with conventional therapy, compared with conventional therapy alone, reduced the risk of death in stage I by 95{\%}, stage II by 64{\%}, stage III by 29{\%}, and stage IV by 75{\%}. There was no significant difference between short-term and long-term PAM+V. Combining PAM+V with conventional therapy improved survival, compared with conventional therapy alone, suggesting that prospective trials combining PAM+V with conventional therapy are justified.",
keywords = "chemotherapy, Chinese herbal medicine, colon cancer, marginal structural models, propensity score, radiotherapy, survival, vitamins",
author = "Michael McCulloch and Michael Broffman and {Van Der Laan}, Mark and Alan Hubbard and Lawrence Kushi and Abrams, {Donald I.} and Jin Gao and Colford, {John M.}",
year = "2011",
month = "9",
doi = "10.1177/1534735411406539",
language = "English (US)",
volume = "10",
pages = "240--259",
journal = "Integrative Cancer Therapies",
issn = "1534-7354",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach

T2 - Ten-year follow-up data analyzed with marginal structural models and propensity score methods

AU - McCulloch, Michael

AU - Broffman, Michael

AU - Van Der Laan, Mark

AU - Hubbard, Alan

AU - Kushi, Lawrence

AU - Abrams, Donald I.

AU - Gao, Jin

AU - Colford, John M.

PY - 2011/9

Y1 - 2011/9

N2 - Although localized colon cancer is often successfully treated with surgery, advanced disease requires aggressive systemic therapy that has lower effectiveness. Approximately 30% to 75% of patients with colon cancer use complementary and alternative medicine (CAM), but there is limited formal evidence of survival efficacy. In a consecutive case series with 10-year follow-up of all colon cancer patients (n = 193) presenting at a San Francisco Bay-Area center for Chinese medicine (Pine Street Clinic, San Anselmo, CA), the authors compared survival in patients choosing short-term treatment lasting the duration of chemotherapy/radiotherapy with those continuing long-term. To put these data into the context of treatment responses seen in conventional medical practice, they also compared survival with Pan-Asian medicine + vitamins (PAM+V) with that of concurrent external controls from Kaiser Permanente Northern California and California Cancer Registries. Kaplan-Meier, traditional Cox regression, and more modern methods were used for causal inference-namely, propensity score and marginal structural models (MSMs), which have not been used before in studies of cancer survival and Chinese herbal medicine. PAM+V combined with conventional therapy, compared with conventional therapy alone, reduced the risk of death in stage I by 95%, stage II by 64%, stage III by 29%, and stage IV by 75%. There was no significant difference between short-term and long-term PAM+V. Combining PAM+V with conventional therapy improved survival, compared with conventional therapy alone, suggesting that prospective trials combining PAM+V with conventional therapy are justified.

AB - Although localized colon cancer is often successfully treated with surgery, advanced disease requires aggressive systemic therapy that has lower effectiveness. Approximately 30% to 75% of patients with colon cancer use complementary and alternative medicine (CAM), but there is limited formal evidence of survival efficacy. In a consecutive case series with 10-year follow-up of all colon cancer patients (n = 193) presenting at a San Francisco Bay-Area center for Chinese medicine (Pine Street Clinic, San Anselmo, CA), the authors compared survival in patients choosing short-term treatment lasting the duration of chemotherapy/radiotherapy with those continuing long-term. To put these data into the context of treatment responses seen in conventional medical practice, they also compared survival with Pan-Asian medicine + vitamins (PAM+V) with that of concurrent external controls from Kaiser Permanente Northern California and California Cancer Registries. Kaplan-Meier, traditional Cox regression, and more modern methods were used for causal inference-namely, propensity score and marginal structural models (MSMs), which have not been used before in studies of cancer survival and Chinese herbal medicine. PAM+V combined with conventional therapy, compared with conventional therapy alone, reduced the risk of death in stage I by 95%, stage II by 64%, stage III by 29%, and stage IV by 75%. There was no significant difference between short-term and long-term PAM+V. Combining PAM+V with conventional therapy improved survival, compared with conventional therapy alone, suggesting that prospective trials combining PAM+V with conventional therapy are justified.

KW - chemotherapy

KW - Chinese herbal medicine

KW - colon cancer

KW - marginal structural models

KW - propensity score

KW - radiotherapy

KW - survival

KW - vitamins

UR - http://www.scopus.com/inward/record.url?scp=84855363459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855363459&partnerID=8YFLogxK

U2 - 10.1177/1534735411406539

DO - 10.1177/1534735411406539

M3 - Article

VL - 10

SP - 240

EP - 259

JO - Integrative Cancer Therapies

JF - Integrative Cancer Therapies

SN - 1534-7354

IS - 3

ER -